To treat a skeletal muscle atrophy.

The invention relates to the method for treating the skeletal muscle atrophy in a sample in need of treatment for the skeletal muscle atrophy comprising a process introducing an expression vector encoding an active CRF2R, an expression vector for encoding an constitutive active type CRF2R, or an expression vector for encoding CRF into cells obtained from a human.